US Stock MarketDetailed Quotes

ARCT Arcturus Therapeutics

Watchlist

18.050
+1.640+9.99%

Close Feb 14 16:00 ET

18.000
-0.050-0.28%

Post 20:01 ET

488.93MMarket Cap-7.75P/E (TTM)

Arcturus Therapeutics Stock Forum

10baggerbamm

Feb 14 09:59

$Arcturus Therapeutics (ARCT.US)$ unless there's a massive breakout and I don't see it coming you want to put a buy order in right around $15.80-15.90
you'll want to keep an eye when it cycles back down because the last cycle it did dip a little lower didn't break any support lines but it immediately reversed.
Bill Gates doesn't invest to lose and he's bankrolling this company so there's favorable news that's regularly coming out of this company that causes it to trade higher

10baggerbamm

Feb 14 08:47

$Arcturus Therapeutics (ARCT.US)$ I mentioned this the other day the stock is in a nice channel you buy it on the lower support and there's news that comes out like clockwork you can see it today this is a Bill Gates back company he's pumping money into them

Teddy123

Feb 14 07:08

European Commission Approves CSL and Arcturus Therapeutics’ KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine

$Arcturus Therapeutics (ARCT.US)$
Revolutionary COVID Vaccine Breakthrough: EU Approves KOSTAIVE with Year-Long Immunity Power

Teddy123

Jan 31 02:33

Meiji Seika Pharma Receives Approval for Adding Domestic Manufacturing Sites in Japan for KOSTAIVE®, a Self-amplifying mRNA Vaccine Against COVID-19

$Arcturus Therapeutics (ARCT.US)$
Japan's COVID Vaccine Independence: Meiji Gets Green Light for Local KOSTAIVE Production

10baggerbamm

Jan 7 13:32

$Arcturus Therapeutics (ARCT.US)$at least I own one stock that's not going down today

10baggerbamm

Jan 7 08:55

$Arcturus Therapeutics (ARCT.US)$ hmm look what keeps going up... I posted this a few days ago you can go look this is a company that Bill gates's Bank rolling

10baggerbamm

Dec 29, 2024 00:16

$Arcturus Therapeutics (ARCT.US)$ this company is associated with Bill and Melinda Gates Foundation. they are in the process of developing a bird flu vaccination. the vaccine they're calling a pandemic injection.
out of California within the past couple of weeks you have Governor New scum talking about bird flu.. I've heard it mentioned on a couple of the fake news stations this past week. and now the self-proclaimed expert in medicine who believes that the world must be depopulated by 90% but i...

10baggerbamm OP : as a follow-up this is where you use options because you know exactly the risk going in you know what your loss is going to be.
unfortunately June of 25 is as far out as the contracts go. buying it out of the money contract and throwing a bid in which there's zero bid is what I'm going to do.. so I'll throw different bids in for a nickel $0, .10, .20 different amounts of contracts.. and see if I get filled

Report
Reply

Cancel Reply
10baggerbamm OP : additionally if you look at transactions in December you have acquisitions of stock by four parties within the company three are 60,000 shares one is 190,000 shares.
as they say people sell stock for variety of reasons but they buy stock for only one.

Report
Reply

Cancel Reply
10baggerbamm OP : 11/11/2024 - 04:01 PM
SAN DIEGO--(BUSINESS WIRE)-- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has issued a “Study Can Proceed” notification for the Company’s Investigational New Drug (IND) application, ARCT-2304, a self-amplifying mRNA (sa-mRNA) vaccine candidate for active immunization to prevent pandemic influenza disease caused by H5N1 virus. The clinical study is funded by Biomedical Advanced Research and Development Authority (BARDA) and designed to enroll approximately 200 healthy adults in the United States.

Report
Reply

Cancel Reply
10baggerbamm OP :

Report
Reply

Cancel Reply
10baggerbamm OP : https://expose-news.com/2024/12/18/self-replicating-vaccine-trial-in-the-usa/

Report
Reply

Cancel Reply

View more comments...

Laurence john tawil

May 28, 2024 10:16

$Arcturus Therapeutics (ARCT.US)$ wtf is happening bout to put this hoe down

Moomoo AI

Mar 9, 2024 06:57

Analysts maintain loss per share estimates for next year with no major changes to revenue estimates. However, the company's performance is expected to underperform the wider industry. The steady consensus price target indicates that reduced loss estimates may not positively impact the stock's long-term valuation.

Analysts Have Made A Financial Statement On Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) Yearly Report

Moomoo AI

Feb 28, 2024 06:46

Despite Arcturus Therapeutics Holdings Inc.'s strong run, its P/S ratio remains low due to a weak revenue outlook. Investors believe the potential for revenue improvement doesn't justify a higher P/S ratio, forming a barrier for the share price.